Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
1. Evaluate the efficacy and safety of taking thalidomide tablets once daily in the treatment of active ankylosing spondylitis. 2. To explore dose-effect relationships of taking thalidomide tablets once daily in the treatment of active ankylosing spondylitis, as well as selecting the appropriate dose for the further larger scale clinical trials.
Epistemonikos ID: 7ce7344552d8b9e3cab57c7bac117675908a083f
First added on: May 12, 2024